Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The objective of the newsletter

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Mar 02, 2022 11:06am

167 Views

Post# 34474939

RE:RE:The objective of the newsletter

Agreed, Fred. It is simply good business practice to keep the stake holders informed of any developments, even if is just a short update on 1. Results vs Goals, 2. Major Opportunities vs Challenges 3. Short and Longterm plans with specific timelines and overall health of the company. It is simple and straight forward transperancy that should be integral to the core values of any company.

<< Previous

Bullboard Posts

Next >>

NTG Clarity Networks' growth story continues with $22M contract